We have assembled leading scientists from San Francisco Bay Area biotechnology companies who will each share a story of how their company took an idea, developed it, and transformed it into a therapeutic.  You will hear speakers from Amgen, NGM Bio, Bristol-Myers Squibb, Global Blood Therapeutics, and Merck and learn about drug development at these companies and the associated challenges.